Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. Sure…

この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. Sure…
この記事を読む
Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small ce…
この記事を読む
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cance…
この記事を読む
Disparities in the Diagnosis and Treatment of Lung Can∺er among People with Disabilities. Shin DW et al. J Thorac Oncol.…
この記事を読む
Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032. Ready N et al. J Thorac Oncol. 2019 Feb;14(2):237-244…
この記事を読む
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial. Cho J et a…
この記事を読む
Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Latham A et al. J Clin Oncol. 2…
この記事を読む
Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study. Gandara D…
この記事を読む
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Sys…
この記事を読む
New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter coh…